Exploring direct and indirect targets of current antileishmanial drugs using a novel thermal proteomics profiling approach

Exploring direct and indirect targets of current antileishmanial drugs using a novel thermal proteomics profiling approach

Visceral leishmaniasis (VL), caused by Leishmania infantum, is an oft-fatal neglected tropical disease. In the absence of an effective vaccine, the control of leishmaniasis relies exclusively on chemotherapy. Due to the lack of established molecular/genetic markers denoting parasite resistance, clin...

Full description

Bibliographic Details
Main Authors:	Ana Victoria Ibarra-Meneses, Audrey Corbeil, Victoria Wagner, Francis Beaudry, Rubens L. do Monte-Neto, Christopher Fernandez-Prada
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	Leishmania antileishmanial drugs mode of action thermal proteome profiling drug resistance antimony
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.954144/full

Similar Items

Identification of asymptomatic Leishmania infections: a scoping review
by: Ana Victoria Ibarra-Meneses, et al.
Published: (2022-01-01)

Neutrophil Activation: Influence of Antimony Tolerant and Susceptible Clinical Strains of L. (V.) panamensis and Meglumine Antimoniate
by: Olga Lucía Fernández, et al.
Published: (2021-09-01)

Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan
by: Chloé Rosa-Teijeiro, et al.
Published: (2021-08-01)

MRPA-independent mechanisms of antimony resistance in Leishmania infantum
by: Noélie Douanne, et al.
Published: (2020-08-01)

Separation and evaluation of natural antileishmanial potential against Leishmania major and infuntum isolated from the Tunisia strains
by: Salwa Bouabdallah, et al.
Published: (2018-03-01)

Antileishmanial activity of lapachol analogues
by: Nadja MF Lima, et al.
Published: (2004-11-01)

In Vitro Assessment of Antileishmanial Activity of Natamycin and Nystatin
by: Arushdeep Sidana, et al.
Published: (2017-05-01)

Synthesis of 4-substituted ethers of benzophenone and their antileishmanial activities
by: Faiza Ahad, et al.
Published: (2018-01-01)

Synthesis and antileishmanial activity of styrylquinoline-type compounds: <em>in vitro</em> and <em>in vivo</em> studies
by: F. A. Petro-Buelvas, et al.
Published: (2021-06-01)

In vitro Antileishmanial Activity of Some Ethiopian Medicinal Plants
by: Nigatu H, et al.
Published: (2021-01-01)

Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
by: Arijit Bhattacharya, et al.
Published: (2020-06-01)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
by: Isabel M. Vincent, et al.
Published: (2015-10-01)

Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress
by: Rubens Lima do Monte Neto, et al.
Published: (2022-03-01)

4-Acetoxydolastane Diterpene from the Brazilian Brown Alga Canistrocarpus cervicornis as Antileishmanial Agent
by: Elizandra Aparecida Britta, et al.
Published: (2011-11-01)

Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity
by: Samanta Etel Treiger Borborema, et al.
Published: (2016-04-01)

In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues
by: Mohamed Jawed Ahsan, et al.
Published: (2016-06-01)

Identification of Chalcone Derivatives as Inhibitors of Leishmania infantum Arginase and Promising Antileishmanial Agents
by: Andreza R. Garcia, et al.
Published: (2021-01-01)

Antileishmanial activity of a formulation of 2-n-propylquinoline by oral route in mice model
by: Campos Vieira N., et al.
Published: (2011-11-01)

Antileishmanial in vitro activity of essential oil from Myrciaria plinioides, a native species from Southern Brazil
by: Carla Kauffmann, et al.
Published: (2019-10-01)

Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2′-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment
by: Luiz Filipe Gonçalves Oliveira, et al.
Published: (2018-04-01)

Potential selection of antimony and methotrexate cross-resistance in Leishmania infantum circulating strains.
by: Lorena Bernardo, et al.
Published: (2024-02-01)

Antileishmanial activity of the essential oil from Tetradenia ripariaobtained in different seasons
by: Bruna Muller Cardoso, et al.
Published: (2015-01-01)

Bioprospecting marine actinomycetes for antileishmanial drugs: current perspectives and future prospects
by: O.F. Davies-Bolorunduro, et al.
Published: (2021-08-01)

In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids
by: Ifedayo Victor Ogungbe, et al.
Published: (2013-07-01)

Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties
by: Hannah N. Corman, et al.
Published: (2022-12-01)

Thiophene Derivatives with Antileishmanial Activity Isolated from Aerial Parts of Porophyllum ruderale (Jacq.) Cass.
by: Celso Vataru Nakamura, et al.
Published: (2011-04-01)

Antileishmanial Activity of BNIPDaoct- and BNIPDanon-loaded Emulsomes on Leishmania infantum Parasites
by: Zeynep Islek, et al.
Published: (2022-01-01)

Antileishmanial activity of Ferula assa-foetida oleo gum resin against Leishmania major: An in vitro study
by: Ali Fatahi Bafghi, et al.
Published: (2014-01-01)

Assessment of in-vitro antileishmanial activities of cynara scolymus extracts against leishmania tropica
by: Ahmet YILDIRIM, et al.
Published: (2021-06-01)

Antileishmanial activity and immunomodulatory effect of secosubamolide, a butanolide isolated from Nectandra oppositifolia (Lauraceae)
by: Thais A. da Costa-Silva, et al.

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
by: Philippe M. Loiseau, et al.
Published: (2022-04-01)

Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions
by: Ivo B. Regli, et al.
Published: (2018-12-01)

Evaluation of antileishmanial activity of plants used in Indian traditional medicine
by: Arushdeep Sidana, et al.
Published: (2015-05-01)

Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents
by: Ahmed H.E. Hassan, et al.
Published: (2023-11-01)

Current application of arylazoles and annulated azoles in the design of new antileishmanial agents
by: Masoud Keighobadi, et al.
Published: (2017-10-01)

Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects
by: Rajamanthrilage Kasun Madusanka, et al.
Published: (2024-01-01)

Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis
by: Marlene Jara, et al.
Published: (2023-09-01)

Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil
by: Lucas S Magalhães, et al.

Improved Antileishmanial Activity of Dppz through Complexation with Antimony(III) and Bismuth(III): Investigation of the Role of the Metal
by: Cynthia Demicheli, et al.
Published: (2012-10-01)

Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme
by: Md. Sakhawat Hossain, et al.
Published: (2018-08-01)